- Home
- EEA vs FORA Comparison
EEA vs FORA Comparison
Compare EEA & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EEA | FORA |
|---|---|---|
| Founded | 1986 | 2014 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.6M | 66.2M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | EEA | FORA |
|---|---|---|
| Price | $9.99 | $2.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 50.3K | 19.4K |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | N/A | ★ 25.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,256,919.00 |
| Revenue This Year | N/A | $8.44 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 50.13 |
| 52 Week Low | $8.21 | $1.64 |
| 52 Week High | $11.43 | $2.71 |
Technical Indicators
Market Signals| Indicator | EEA | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 44.95 | 68.28 |
| Support Level | $9.99 | $2.04 |
| Resistance Level | $10.84 | $2.16 |
| Average True Range (ATR) | 0.30 | 0.03 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 34.48 | 73.72 |
Price Performance
Historical ComparisonAbout EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.